Caution in Use – Chemidex Pharma Ltd

19th May 2025

Chemidex Pharma Ltd has issued a Class 4 Medicines Defect Information –  Caution in Use.

In relation to:

Brief description of the problem

Chemidex Pharma Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in their topical steroid products does not contain all the required safety information. Cartons for the products/batches listed are missing side effect information related to Visual Disturbances.

The batches listed as ‘not yet distributed’ have also been packed with the PIL that is missing the additional side effect information. The MHRA, in discussion with the Department of Health and Social Care, considers these products critical for patients, therefore these batches will not be repackaged and continue to be distributed. They are therefore included in the notification and the expected distribution dates for these batches will take place from May 2025.

Whist NVS has not received or distributed any of affected products & batches we do offer three of the affected products as Special-order items.

NVS Product Code(s)

Product Description Affected Batch No’s Expiry Date First Distributed
568545 Prednisolone 20mg Rectal Foam, 14D XDAM June-2025 Aug-2024
XDAN Mar-2026 Jan-2025
XDANA Mar-2027 Not yet Distributed
89047 Hydrocortisone Cream 2.5%@@, 15G 5155032 Oct-2026 Jan-2025
89059 Hydrocortisone Oint 2.5% @@, 15G. 5152598 Sep-2025 April-2023
5153432 May-2026 Aug-2023
5154575 Apr-2027

Aug-2024

 

Advice for healthcare professionals

There is no risk to product quality because of this issue, therefore the affected batches are not being recalled. Healthcare professionals are advised to exercise caution when dispensing the products and where possible, provide an updated PIL.

What to do next – Please read the attached notification letter (Please click here) and bring the issue to the attention of all relevant colleagues within your business. The updated PIL is available electronically and can be downloaded from the links within the notification letter:

National Veterinary Services
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.